Admedus

---

May 17, 2018: In The Know

May 16, 2018 | Tags: Admedus, Aldevron, Be The Match, Biothera Pharmaceuticals, Blue Cross and Blue Shield of Minnesota, Boston Scientific, Coloplast, Ecolab, Electromed, Mayo Clinic, Medtronic, RxFunction, Sanofi, Sun BioPharma, University of Minnesota, Vyriad

Ecolab Ranks Eighth on 2018 Best Corporate Citizens List

Why Medtronic’s CEO Wants to Bring Values-Based Healthcare to Everyone

Boston Scientific’s drug-coated balloon succeeds in femoropopliteal segment at one year

U of M Honored as One the World’s Best at Spinning Off Companies from Research

Coloplast Announces the Launch of Biatain® Silicone with 3DFit Technology™

Blue Cross and Blue Shield of Minnesota Releases 2017 Community Report

Successful Commercialization of Gut Microbe Strain Could Net Mayo $55M

Minnesota med-tech industry seeks China tariff relief

Vyriad to build $9 million facility on former IBM site

Medtronic Begins U.S. Study of Drug-Eluting Stents to Evaluate Treatment of Bifurcation Lesions in Patients with Coronary Artery Disease

Research Brief: UMN researchers make key discovery about human cancer virus protein

Women in Business Awards 2018: Kathleen Skarvan

Q&A With Chris McClain, VP of New Business Development and Sales

Biothera Pharmaceuticals Appoints Andrew D.C. LaFrence Chief Financial Officer

walkasins Tested for Longer-Term Effectiveness in Peripheral Neuropathy

Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis

Aldevron Names Marc Wolff Chief Financial Officer

Sun BioPharma Provides Business Update and Files Report for Q1 2018

Admedus using capital raised to advance product development and share price growth

---

May 3, 2018: In The Know

May 2, 2018 | Tags: 3M, Admedus, Ambient Clinical, ANI Pharmaceuticals, Cardionomic, DSI, Electromed, Mayo Clinic, Medibio, Medtronic, Microoptx, Minnetronix, Osprey Medical, Summit Medical, University of Minnesota

Made at Mayo: How Lifting a Startup Ban at One of the Nation’s Top Health Systems Ushered in a Wave of Innovation in Rochester

 

Entrepreneur of the Year Heartland Finalists Revealed, Minnesota Dominates Again

Electromed, Inc. Announces Results of a Longitudinal Outcome-Based Study: Bronchiectasis Exacerbations Significantly Reduced with HFCWO Therapy

ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax

Cardionomic Nears Close of $9.6M Series B

Minne Ties® Agile MMF by Summit Medical Named Finalist for Medical Design Excellence Award

Ambient Clinical Analytics Solutions Proves Crucial in Saving Life

Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants to Enhance Neuroscience Research

Medtronic Announces TiONIC(TM) Technology, a Titanium 3D Printed Platform for Spine Surgery Implants

Osprey Medical posts double-digit sales growth for DyeVert Plus system

Minnetronix Announces Appointment of Elissa Lindsoe as Chief Financial Officer

Medibio Announces Global Launch of Corporate Mental Health For Business

Admedus appoints medtech expert Michael Oswell as vice president, development

3M Announces FDA Clearance of New Biological Indicator System Providing 24-Minute Results for Steam Sterilization

The Eyes Have It

UMN faculty member appointed to new federal pain management task force

---

September 28, 2017: In the Know

September 28, 2017 | Tags: 3M, Abbott, Admedus, Boston Scientific, DoseMe, Mayo, Teva

1. How Can Digital Health Alleviate Common Healthcare Pain Points?
2. Post-Maria, Med-Tech Firms in Puerto Rico Work to Track Down Workers
   
3. US Department of Defense Awards Humanetics Corporation $3.8 Million Grant for Advanced Development of Radiation Drug
   
4. DoseMe Wins Place in Inaugural ANDHealth+ Program
   
5. HealthLink Europe & International Acquired by Base Logistics Group
6. Teva’s Migraine Candidate Shows Promising Late-Stage Data 
7. Boston Scientific Touts 3-year Alair Follow-up Study Results 
8. 3M Establishes a Global Relief Fund to Help Communities Affected by Recent Natural Disasters
   
9. Inspire Medical Systems’ Inspire Therapy for Reducing Obstructive Sleep Apnea Demonstrates Long-term Safety and Sustained Benefit Following 5 Years of Treatment
   
10. Metavention CEO hops to another VC-backed startup
11. Admedus CEO Ready To Transform Company Again With TAVR
    
12. Abbott Labs gets FDA approval for MRI-friendly defibrillator
    
13. Mayo Research into Microbiome-Nutrition Connection Lands ADM’s Backing

---

September 6, 2017: In the Know

September 6, 2017 | Tags: Admedus, Electromed, Mayo, Osprey Medical, VigiLanz

1. Study Concludes Vagal Nerve Blocking Therapy is Cost-Effective
   
2. A Seat at the Table: Healthcare Tech Leaders Form Unique Board
   
3. Mayo Clinic Researchers Review the Clinical Potential of Senolytic Drugs on Aging
4. Electromed, Inc. Announces Fiscal 2017 Fourth Quarter Financial Results
5. Here are the Startups in gener8tor’s First Minnesota Accelerator
6. Admedus eyes new revenue stream through supply agreement with 4C Medical Technologies
7. VigiLanz Achieves Top Rating for Overall Satisfaction in KLAS AMS Performance Report
   
8. Local Study May Keep More Hearts Beating
9. Osprey Medical Bags $10.3M as Sales Gain Momentum

---